AINDEX
Markets

Blue Water Acquisition Corp. III (BLUWW)

BLUWWNASDAQ-GMN/A

$0.0800

+0.0084 (+11.73%) today

Regular session, Nov 17, 1:28 PM ET

+11.73% 1D
Market cap
$579.6k
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
$0.0700 to $0.0800
52-week range
$0.0682 to $0.8500
Average volume
–
Previous close
$0.0716

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue––––
Gross profit––––
Operating income-$517.0k-$354.0k-$198.0k-$242.0k
Net income$2.01m$1.93m$2.10m$2.13m

News

8 latest

The company

Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com.

Sector
N/A
Industry
N/A
Exchange
NASDAQ-GM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.